Tackling dermatomyositis with cancer therapy
Tricia was very active, but dermatomyositis nearly stopped her in her tracks
Forty years ago, Jerry Mendell, MD, an internationally known expert in Duchenne’s muscular dystrophy, founded what has grown into the Ohio State Neuromuscular Center, one of the largest nerve and muscle centers in the United States, focusing on excellent care for patients with nerve and muscle disease and state-of-the-art clinical and basic research. Our Neuromuscular Center serves our Neurological Institute, which brings together physicians, scientists, nurses and therapists to develop new technologies and better treatments for people with complex neurological conditions.
Researchers at our Neuromuscular Center have carried out hallmark research in Duchenne’s muscular dystrophy, have identified a critical mechanism in the pathology of dermatomyositis and are now involved in gene therapy trials for disorders including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
Because the Neuromuscular Center houses both an inpatient plasmapheresis laboratory and an outpatient infusion service, patients can undergo any necessary autoimmune treatments without having to travel to another facility. The center also offers a variety of rehabilitative services including a full-time respiratory therapist, physical therapist and genetic counselor.
Amy Bartlett, BA, CCRC
NeuroNEXT Clinical Research Manager
Amy.Bartlett@osumc.edu
614-366-9050
Donna Oakes
Medical Administrative Assistant
Donna.Oakes@osumc.edu
Filiz Muharrem
Clinical Research Coordinator
Filiz.Muharrem@osumc.edu